Guangzhou Panyu Central Hospital

Guangzhou, Guangdong 511400

0 studies enrolling now · 2 studies all time

What they study most

Atrial Fibrillation, Nasopharyngeal Carcinoma, Prevention of Stroke or Systemic Embolism

Studies at this site

• A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma — Running, not enrolling
• A Study to Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke — Stopped early